Graph AI
United States · Healthtech · AI
An AI-native pharmacovigilance platform that helps pharmaceutical safety teams process adverse-event cases, connect evidence and prepare regulatory reporting while keeping experts in control of safety decisions.
Product
Graph Safety helps pharmaceutical and biotech safety teams capture, classify and process adverse-event reports. Intake captures and triages reports, while Nucleus supports case processing with validation controls, audit trails and expert review.
The company scheduled its Report module for aggregate reporting in September 2026. Signal detection, continuous assurance and compliance modules are described as later milestones. Graph AI reports that live deployments reduced case-processing time from more than three hours to under 10 minutes.
- Current workflows
- Intake, case processing and reporting
- Headquarters
- Pleasanton, California
Funding history
1 round · 1 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $13.3M | Insight Partners — LeadBessemer Venture Partners — Participant |